Redhill Biophrma ADR (RDHL)

$1.90 -0.32 (-14.41%)
Market Cap 6.33M
Revenue (ttm) 8.04M
Net Income (ttm) -8.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -102.86%
Debt to Equity Ratio 0.00
Volume 228,400
Avg Vol 1,235,996
Day's Range N/A - N/A
Shares Out 3.33M
Stochastic %K 24%
Beta 4.57
Analysts Strong Buy
Price Target $40.00

Company Profile

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear ra...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 3 541 3131
Fax: 972 3 541 3144
Address:
21 Ha’arba’a Street, Tel Aviv, Israel
Stockking24
Stockking24 Oct. 3 at 7:53 PM
$RDHL lol under $2 bahaha
0 · Reply
Patrick2343
Patrick2343 Oct. 3 at 2:57 PM
$RDHL pump and dump its all the company is but I am so far underwater I cannot even dump it
0 · Reply
ItTakesItAll
ItTakesItAll Oct. 3 at 2:31 PM
Remarkable week: 2/2🎈 DFLI 760%+ .19-1.34 TBH 475%+ .5555-3.21 SPRC 355%+ 2.34-8.90 RVYL 100%+ .299-.62 IBG 100%+ 2.66-5.38 $CRE 50%+ .85-1.30 $HCTI 45%+ 2.48-3.72 $TNMG 40%+ .2949-.4183 $MASK 35%+ .68-.95 $RDHL 30%+ 2.51-3.36 SEED 25%+ 1.30-1.67 KAVL 20%+ .56-.68 AIHS 20%+ 2.44-3.0
4 · Reply
bigterabytes
bigterabytes Oct. 3 at 1:20 PM
$RDHL $QCLS 🔥🔥🔥🔥
0 · Reply
HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:41 AM
Looks like volume & momentum could be shifting in to ASTC! Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $BURU $CDIO $RDHL $SPRB $VRAX 22
0 · Reply
tatanka9
tatanka9 Oct. 2 at 11:49 PM
$RDHL REDSCAM!!!!
0 · Reply
Michl2000
Michl2000 Oct. 2 at 9:29 PM
$RDHL glad to have sold these worthless shares at 2.46$ 🎉🥳🙏🙏🙏
0 · Reply
Stockking24
Stockking24 Oct. 2 at 7:26 PM
$RDHL and just like that heading back under $2 lmfao 🤣 what a joke like I said until it can get back above $4 and stay sustaining this one’s a no..
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 6:49 PM
$RDHL Pumpers Whats up
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 5:24 PM
$RDHL scam
0 · Reply
Latest News on RDHL
RedHill Wins New York Supreme Court Appeal, Upholding $10 Million Summary Judgment Against Kukbo

Sep 29, 2025, 7:00 AM EDT - 5 days ago

RedHill Wins New York Supreme Court Appeal, Upholding $10 Million Summary Judgment Against Kukbo

RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights

Sep 5, 2025, 7:00 AM EDT - 4 weeks ago

RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights

RedHill Biopharma Awarded $1.8 Million in Legal Costs and Expenses by New York Supreme Court in Addition to its Prior $8.25 Million Summary Judgment Win

Aug 20, 2025, 9:00 AM EDT - 6 weeks ago

RedHill Biopharma Awarded $1.8 Million in Legal Costs and Expenses by New York Supreme Court in Addition to its Prior $8.25 Million Summary Judgment Win

RedHill Received Talicia® Licensing Payments Totaling $1.1 Million

Aug 18, 2025, 9:00 AM EDT - 6 weeks ago

RedHill Received Talicia® Licensing Payments Totaling $1.1 Million

RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease

Jul 21, 2025, 9:00 AM EDT - 2 months ago

RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease

RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer

Jul 1, 2025, 12:00 PM EDT - 3 months ago

RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer

RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win

May 13, 2025, 7:00 AM EDT - 5 months ago

RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win

RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress

May 2, 2025, 7:00 AM EDT - 5 months ago

RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress

RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107

Apr 28, 2025, 7:03 AM EDT - 5 months ago

RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107

RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Apr 17, 2025, 4:01 PM EDT - 6 months ago

RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

RedHill Biopharma's Positive Opaganib Weight Loss & Diabetes Data Published: Signals Potential $100B Market Disruption

Apr 16, 2025, 7:00 AM EDT - 6 months ago

RedHill Biopharma's Positive Opaganib Weight Loss & Diabetes Data Published: Signals Potential $100B Market Disruption

RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights

Apr 10, 2025, 7:48 AM EDT - 6 months ago

RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights

RedHill Biopharma to Submit FDA-Approved Talicia® for UK Marketing Authorisation

Mar 18, 2025, 7:00 AM EDT - 7 months ago

RedHill Biopharma to Submit FDA-Approved Talicia® for UK Marketing Authorisation

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results

Mar 12, 2025, 7:00 AM EDT - 7 months ago

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results

RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum

Feb 27, 2025, 7:00 AM EST - 7 months ago

RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties

Feb 25, 2025, 7:00 AM EST - 7 months ago

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer

Feb 4, 2025, 7:00 AM EST - 8 months ago

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published

Jan 21, 2025, 7:00 AM EST - 9 months ago

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published

Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development

Dec 10, 2024, 7:00 AM EST - 10 months ago

Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

Dec 2, 2024, 7:00 AM EST - 10 months ago

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND

Oct 28, 2024, 7:00 AM EDT - 1 year ago

RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury

Oct 22, 2024, 7:00 AM EDT - 1 year ago

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury

RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment

Oct 14, 2024, 7:00 AM EDT - 1 year ago

RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment

RedHill and Medi-Cal Deal Maintains Talicia® Reimbursement Without Prior Authorization for 15 Million Californians

Oct 1, 2024, 7:00 AM EDT - 1 year ago

RedHill and Medi-Cal Deal Maintains Talicia® Reimbursement Without Prior Authorization for 15 Million Californians

RedHill Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041

Sep 30, 2024, 7:00 AM EDT - 1 year ago

RedHill Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041

RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines

Sep 9, 2024, 7:00 AM EDT - 1 year ago

RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 5, 2024, 7:00 AM EDT - 1 year ago

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

New Peer-Reviewed Publication of Opaganib Phase 2/3 Data Shows 62% Reduction in COVID-19 Mortality

Sep 3, 2024, 7:00 AM EDT - 1 year ago

New Peer-Reviewed Publication of Opaganib Phase 2/3 Data Shows 62% Reduction in COVID-19 Mortality

RedHill Biopharma Announces First Half 2024 Business Highlights

Aug 29, 2024, 7:00 AM EDT - 1 year ago

RedHill Biopharma Announces First Half 2024 Business Highlights

RedHill's Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma

Aug 26, 2024, 7:00 AM EDT - 1 year ago

RedHill's Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma

Talicia® Launched in the United Arab Emirates

Aug 21, 2024, 7:00 AM EDT - 1 year ago

Talicia® Launched in the United Arab Emirates

Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes

Aug 19, 2024, 8:56 AM EDT - 1 year ago

Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes

RedHill Announces Positive Obesity and Diabetes Results with Opaganib

Aug 19, 2024, 7:00 AM EDT - 1 year ago

RedHill Announces Positive Obesity and Diabetes Results with Opaganib

RedHill Biopharma Announces Plan to Implement ADS Ratio Change

Aug 16, 2024, 7:00 AM EDT - 1 year ago

RedHill Biopharma Announces Plan to Implement ADS Ratio Change

Newly Published Positive Phase 3 Data Demonstrates 64% Increased Efficacy with RedHill's RHB-104 in Crohn's Disease

Aug 1, 2024, 7:00 AM EDT - 1 year ago

Newly Published Positive Phase 3 Data Demonstrates 64% Increased Efficacy with RedHill's RHB-104 in Crohn's Disease

RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien

Jul 22, 2024, 7:00 AM EDT - 1 year ago

RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien

RedHill Biopharma Terminates License Agreement for Aemcolo®

Jul 9, 2024, 8:00 AM EDT - 1 year ago

RedHill Biopharma Terminates License Agreement for Aemcolo®

RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040

Jun 3, 2024, 7:00 AM EDT - 1 year ago

RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040

RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035

May 6, 2024, 7:00 AM EDT - 1 year ago

RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study

Apr 24, 2024, 7:00 AM EDT - 1 year ago

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights

Apr 8, 2024, 9:23 AM EDT - 1 year ago

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price

Apr 2, 2024, 7:00 AM EDT - 1 year ago

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price

RedHill Announces New USPTO Patent Covering Talicia® Through 2034

Mar 11, 2024, 7:00 AM EDT - 1 year ago

RedHill Announces New USPTO Patent Covering Talicia® Through 2034

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

Mar 5, 2024, 7:00 AM EST - 1 year ago

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

GILD

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication

Feb 20, 2024, 7:00 AM EST - 1 year ago

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication

AMGN GILD

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering

Jan 26, 2024, 12:46 PM EST - 1 year ago

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering

RedHill Biopharma Announces $8 Million Registered Direct Offering

Jan 25, 2024, 9:05 AM EST - 1 year ago

RedHill Biopharma Announces $8 Million Registered Direct Offering

RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042

Jan 25, 2024, 6:00 AM EST - 1 year ago

RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042

RedHill Biopharma shares jump as Ebola treatment shows promise

Dec 20, 2023, 9:13 AM EST - 1 year ago

RedHill Biopharma shares jump as Ebola treatment shows promise

RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola

Dec 20, 2023, 8:45 AM EST - 1 year ago

RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola

Stockking24
Stockking24 Oct. 3 at 7:53 PM
$RDHL lol under $2 bahaha
0 · Reply
Patrick2343
Patrick2343 Oct. 3 at 2:57 PM
$RDHL pump and dump its all the company is but I am so far underwater I cannot even dump it
0 · Reply
ItTakesItAll
ItTakesItAll Oct. 3 at 2:31 PM
Remarkable week: 2/2🎈 DFLI 760%+ .19-1.34 TBH 475%+ .5555-3.21 SPRC 355%+ 2.34-8.90 RVYL 100%+ .299-.62 IBG 100%+ 2.66-5.38 $CRE 50%+ .85-1.30 $HCTI 45%+ 2.48-3.72 $TNMG 40%+ .2949-.4183 $MASK 35%+ .68-.95 $RDHL 30%+ 2.51-3.36 SEED 25%+ 1.30-1.67 KAVL 20%+ .56-.68 AIHS 20%+ 2.44-3.0
4 · Reply
bigterabytes
bigterabytes Oct. 3 at 1:20 PM
$RDHL $QCLS 🔥🔥🔥🔥
0 · Reply
HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:41 AM
Looks like volume & momentum could be shifting in to ASTC! Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $BURU $CDIO $RDHL $SPRB $VRAX 22
0 · Reply
tatanka9
tatanka9 Oct. 2 at 11:49 PM
$RDHL REDSCAM!!!!
0 · Reply
Michl2000
Michl2000 Oct. 2 at 9:29 PM
$RDHL glad to have sold these worthless shares at 2.46$ 🎉🥳🙏🙏🙏
0 · Reply
Stockking24
Stockking24 Oct. 2 at 7:26 PM
$RDHL and just like that heading back under $2 lmfao 🤣 what a joke like I said until it can get back above $4 and stay sustaining this one’s a no..
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 6:49 PM
$RDHL Pumpers Whats up
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 5:24 PM
$RDHL scam
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 5:16 PM
$RDHL stupid Pumpers
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 5:06 PM
$RDHL easy system
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 5:03 PM
$RDHL easy easy
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 4:14 PM
$RDHL so easy down
1 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 3:57 PM
$RDHL littl pump now skowly Dumping
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 3:43 PM
$RDHL OK newbie
1 · Reply
Michl2000
Michl2000 Oct. 2 at 3:30 PM
$RDHL pc 'f sht
0 · Reply
Michl2000
Michl2000 Oct. 2 at 3:24 PM
$RDHL straight on to the bottom.
0 · Reply
Michl2000
Michl2000 Oct. 2 at 3:20 PM
$RDHL -70% within last 12 months. Great 🥳!
0 · Reply
Homer_Simpson82
Homer_Simpson82 Oct. 2 at 3:14 PM
$RDHL down
0 · Reply
dup007
dup007 Oct. 2 at 2:05 PM
$RDHL 2.5800 +0.0600 +(2.39%) As of 10:03:34 AM EDT. Market Open. Inching up. Nice!
0 · Reply
davis8uni
davis8uni Oct. 2 at 3:15 AM
$RDHL
0 · Reply